Related Experiment Video
Updated: Jan 24, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
Yi He1, Wenyong Long1, Qing Liu1
1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Abstract:
Super-enhancers (SEs) refer to large clusters of enhancers that drive gene expressions. Recent data has provided novel insights in elucidating the roles of SEs in many diseases, including cancer. Many mechanisms involved in tumorigenesis and progression, ranging from internal gene mutation and rearrangement to external damage and inducement, have been demonstrated to be highly associated with SEs. Moreover, translocation, formation, deletion, or duplication of SEs themselves could lead to tumor development. It has been reported that various oncogenic molecules and pathways are tightly regulated by SEs. Moreover, several clinical trials on novel SEs blockers, such as BET inhibitor and CDK7i, have indicated the potential roles of SEs in cancer therapy. In this review, we highlighted the underlying mechanism of action of SEs in cancer development and the corresponding novel potential therapeutic strategies. It is speculated that targeting SEs could complement the traditional approaches and lead to more effective treatment for cancer patients.
Insights
Super-enhancers (SEs) are crucial for gene expression and play a significant role in cancer development. Targeting SEs offers a promising new therapeutic strategy to complement existing cancer treatments.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Super-enhancers (SEs) are large clusters of enhancers that regulate gene expression.
- SEs are increasingly recognized for their critical roles in various diseases, particularly cancer.
- Dysregulation of SEs is linked to tumorigenesis and cancer progression.
Purpose of the Study:
- To review the mechanisms by which SEs contribute to cancer development.
- To explore novel therapeutic strategies targeting SEs for cancer treatment.
Main Methods:
- Literature review of studies on SEs in cancer.
- Analysis of oncogenic pathways regulated by SEs.
- Examination of clinical trials for SEs inhibitors.
Main Results:
- SEs are implicated in diverse cancer mechanisms, including gene mutations, rearrangements, and chromosomal abnormalities.
- Various oncogenic molecules and pathways are tightly controlled by SEs.
- Clinical trials of SEs blockers (e.g., BET inhibitors, CDK7 inhibitors) show therapeutic potential.
Conclusions:
- SEs are key drivers in cancer development and progression.
- Targeting SEs represents a novel and potentially effective approach to cancer therapy.
- SEs-targeted therapies may complement traditional cancer treatments, improving patient outcomes.
More Related Videos
Related Concept Videos
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Self-Evaluation: Self-Enhancement and Self-Verification
Therapeutic Index
Super-resolution Fluorescence Microscopy

